Lumos Laboratories Limited has been nominated for the 2023 edition of the African Excellence Awards. The African Excellence Awards is a yearly award instituted by MEA Markets Magazine to recognize companies and leaders that are spearheading and driving industry across Africa. Lumos Laboratories has been at the forefront of deploying
Very recent studies from well controlled clinical trials show that Remdesivir is very effective against COVID-19. It was gathered that the FDA is expected to issue emergency authorization for it’s use in tackling the virus infection menace! Remdesivir, a drug, was as well used against Ebola, made by Gilead Sciences
The United States Food and Drugs Administration (FDA), a federal agency of the United States Department of Health and Human Services, approves remdesivir as drug for emergency use in treatment of COVID-19. Remdesivir is a broad spectrum antiviral drug that has shown effectiveness in both invitro and in vivo administration.